Hypertension drug developer Mineralys Therapeutics files for $100M IPO
[ad_1] Andranik Hakobyan Hypertension drug developer Mineralys Therapeutics (MLYS) has filed for a $100M initial public offering. The biotech company didn’t specify in its filing the price or number of…